TY - JOUR
T1 - Association of thrombus density and endovascular treatment outcomes in patients with acute ischemic stroke due to M1 occlusions
AU - Bruggeman, Agnetha A. E.
AU - Aberson, Nyk
AU - Kappelhof, Manon
AU - Dutra, Bruna G.
AU - Hoving, Jan W.
AU - Brouwer, Josje
AU - Tolhuisen, Manon L.
AU - Terreros, Nerea Arrarte
AU - Konduri, Praneeta R.
AU - Boodt, Nikki
AU - Roos, Yvo B. W. E. M.
AU - van Zwam, Wim H.
AU - Bokkers, Reinoud
AU - the MR CLEAN Registry Investigators
AU - Martens, Jasper
AU - Marquering, Henk A.
AU - Emmer, Bart J.
AU - Majoie, Charles B. L. M.
N1 - Funding Information:
Amsterdam UMC received funds from Stryker® for consultations by Dr. Majoie and Dr. Roos. Unrelated to this study, Amsterdam UMC received grants from the Netherlands Organization for Health Research and Development, Health Holland Top Sector LSH and Nicolab B.V. Erasmus University Medical Center received funds from Stryker®, Siemens Healthineers and GE Healthcare for consultations by Dr. van der Lugt and Dr. Dippel and Bracco Imaging® for consultation by Dr. Dippel. Maastricht University Medical Center received funds from Stryker®, Cerenovus, Nicolab B.V. and Philips for consultation by Dr. van Zwam. N. Arrarte Terreros received funding from the AMC medical Research B.V. P. Konduri is funded by INSIST: a European Union’s Horizon 2020 research and innovation program. Dr. Roos is minor shareholder of Nicolab B.V. Dr. Marquering is co-founder and shareholder of Nicolab B.V. Dr Majoie reports a grant from the TWIN Foundation. Unrelated to this study, Dr. Majoie is minor shareholder of Nicolab B.V. and reports grants from CVON/Dutch Heart Foundation, European Commission, Health Evaluation Netherlands, and Stryker, all paid to institution. The other authors have no conflicts of interest.
Funding Information:
The MR CLEAN Registry was partly funded by the TWIN Foundation, Erasmus MC University Medical Center, Maastricht University Medical Center, and Amsterdam UMC.
Publisher Copyright:
© 2022, The Author(s).
PY - 2022/9
Y1 - 2022/9
N2 - Purpose: We aimed to study the association of non-contrast CT (NCCT) thrombus density with procedural and clinical outcomes in patients with acute ischemic stroke who underwent endovascular treatment (EVT). Since thrombus density is associated with thrombus location, we focused on M1 occlusions only. Methods: Patients with available thin-slice (< 2.5 mm) NCCT were included from a nationwide registry. Regression models were used to assess the relation between thrombus density (per Hounsfield unit [HU]) and the following outcomes. For reperfusion grade, adjusted common odds ratios (acOR) indicated a 1-step shift towards improved outcome per HU increase in thrombus density. For the binary outcomes of first-pass reperfusion (first-pass extended thrombolysis in cerebral infarction [eTICI] 2C-3, FPR), functional independence [90-day modified Rankin Scale (mRS) score of 0–2] and mortality), aORs were reported. Adjusted β coefficients (aβ) were reported for 24-h NIHSS and procedure duration in minutes. Outcome differences between first-line treatment devices (stent retriever versus aspiration) were assessed with interaction terms. Results: In 566 patients with M1 occlusions, thrombus density was not associated with reperfusion (acOR 1.01, 95% CI 0.99–1.02), FPR (aOR 1.01, 95% CI 0.99–1.03), mortality (aOR 0.98, 95% CI 0.95–1.00), 24-h NIHSS (aβ − 0.7%, 95% CI − 1.4–0.2), or procedure duration (aβ 0.27, 95% CI − 0.05–0.58). In multivariable analysis, thrombus density was associated with functional independence (aOR 1.02, 95% CI 1.00–1.05). No interaction was found between thrombus density and first-line treatment device for any outcome. Conclusion: In patients with M1 occlusions, thrombus density was not clearly associated with procedural and clinical outcomes after EVT.
AB - Purpose: We aimed to study the association of non-contrast CT (NCCT) thrombus density with procedural and clinical outcomes in patients with acute ischemic stroke who underwent endovascular treatment (EVT). Since thrombus density is associated with thrombus location, we focused on M1 occlusions only. Methods: Patients with available thin-slice (< 2.5 mm) NCCT were included from a nationwide registry. Regression models were used to assess the relation between thrombus density (per Hounsfield unit [HU]) and the following outcomes. For reperfusion grade, adjusted common odds ratios (acOR) indicated a 1-step shift towards improved outcome per HU increase in thrombus density. For the binary outcomes of first-pass reperfusion (first-pass extended thrombolysis in cerebral infarction [eTICI] 2C-3, FPR), functional independence [90-day modified Rankin Scale (mRS) score of 0–2] and mortality), aORs were reported. Adjusted β coefficients (aβ) were reported for 24-h NIHSS and procedure duration in minutes. Outcome differences between first-line treatment devices (stent retriever versus aspiration) were assessed with interaction terms. Results: In 566 patients with M1 occlusions, thrombus density was not associated with reperfusion (acOR 1.01, 95% CI 0.99–1.02), FPR (aOR 1.01, 95% CI 0.99–1.03), mortality (aOR 0.98, 95% CI 0.95–1.00), 24-h NIHSS (aβ − 0.7%, 95% CI − 1.4–0.2), or procedure duration (aβ 0.27, 95% CI − 0.05–0.58). In multivariable analysis, thrombus density was associated with functional independence (aOR 1.02, 95% CI 1.00–1.05). No interaction was found between thrombus density and first-line treatment device for any outcome. Conclusion: In patients with M1 occlusions, thrombus density was not clearly associated with procedural and clinical outcomes after EVT.
KW - Reperfusion
KW - Stroke
KW - Thrombectomy
KW - Thrombus density
UR - http://www.scopus.com/inward/record.url?scp=85131564482&partnerID=8YFLogxK
U2 - 10.1007/s00234-022-02971-4
DO - 10.1007/s00234-022-02971-4
M3 - Article
C2 - 35570210
SN - 0028-3940
VL - 64
SP - 1857
EP - 1867
JO - Neuroradiology
JF - Neuroradiology
IS - 9
ER -